StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.17−0.18 (-13.33%)

Close on Nov 16, 2026Market cap $61.40MP/E –Yield –

OKYO Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

OKYO Pharma's enterprise value was $1.52B on May 31, 2023, against $1.37B a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2023May 31, 2023$1.52B-18.4%
2022Dec 30, 2022$1.87B–

More OKYO Pharma figures

See a number that looks wrong?